Cargando…

COPD heterogeneity: implications for management

Detalles Bibliográficos
Autores principales:	Barrecheguren, Miriam, Miravitlles, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794904/ https://www.ncbi.nlm.nih.gov/pubmed/26989488 http://dx.doi.org/10.1186/s40248-016-0053-4

Ejemplares similares

Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD?
por: Barrecheguren, Miriam, et al.
Publicado: (2015)

What have we learned from observational studies and clinical trials of mild to moderate COPD?
por: Barrecheguren, Miriam, et al.
Publicado: (2018)

Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care
por: Barrecheguren, Miriam, et al.
Publicado: (2018)

Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire
por: Núñez, Alexa, et al.
Publicado: (2018)

Long-term antibiotics in COPD: more benefit than harm?
por: Miravitlles, Marc
Publicado: (2013)

Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Monteagudo, Mònica, et al.
Publicado: (2021)

The overlap phenotype: the (missing) link between asthma and COPD
por: Piras, Barbara, et al.
Publicado: (2012)

Preventing readmissions of COPD patients: more prospective studies are needed
por: Nuñez, Alexa, et al.
Publicado: (2020)

Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis
por: Martinez-García, Miguel Angel, et al.
Publicado: (2022)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics
por: Ramon, Maria A, et al.
Publicado: (2017)

COPD symptoms in the morning: impact, evaluation and management
por: Roche, Nicolas, et al.
Publicado: (2013)

Stepwise management of COPD: What is next after bronchodilation?
por: Miravitlles, Marc, et al.
Publicado: (2023)

The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2022)

Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT(®) studies
por: Miravitlles, Marc, et al.
Publicado: (2009)

El trasplante pulmonar en la era COVID: impacto y nuevos paradigmas
por: Barrecheguren, Miriam, et al.
Publicado: (2021)

Practice and knowledge about diagnosis and treatment of alpha-1 antitrypsin deficiency in Spain and Portugal
por: Esquinas, Cristina, et al.
Publicado: (2016)

COPD management: role of symptom assessment in routine clinical practice
por: van der Molen, Thys, et al.
Publicado: (2013)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Understanding the impact of symptoms on the burden of COPD
por: Miravitlles, Marc, et al.
Publicado: (2017)

Chronic bronchial infection in COPD. Is there an infective phenotype?
por: Matkovic, Zinka, et al.
Publicado: (2013)

Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study
por: Calle Rubio, Myriam, et al.
Publicado: (2017)

Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma–COPD overlap (ACO): a scoping review protocol
por: Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof, et al.
Publicado: (2017)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain
por: Barrecheguren, Miriam, et al.
Publicado: (2022)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment
por: Aisanov, Zaurbek, et al.
Publicado: (2018)

Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2018)

Economic Impact of Low Adherence to COPD Management Guidelines in Spain
por: Miravitlles, Marc, et al.
Publicado: (2021)

Correction: Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2019)

Time To Revise COPD Treatment Algorithm
por: Matsunaga, Kazuto, et al.
Publicado: (2019)

Bronchiectasis in COPD patients: more than a comorbidity?
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2017)

Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach
por: Belmonte, Irene, et al.
Publicado: (2016)

The concept of control of COPD in clinical practice
por: Soler-Cataluña, Juan José, et al.
Publicado: (2014)

How to get the most out of the ERS International Congress 2021 and an overview of the Early Career Member session
por: Farr, Amy, et al.
Publicado: (2021)

A review of national guidelines for management of COPD in Europe
por: Miravitlles, Marc, et al.
Publicado: (2016)

Caregivers’ burden in patients with COPD
por: Miravitlles, Marc, et al.
Publicado: (2015)

Enhancing the diagnosis and management of COPD in Primary care
por: Partridge, Martyn R
Publicado: (2014)

Identifying possible asthma–COPD overlap syndrome in patients with a new diagnosis of COPD in primary care
por: Baarnes, Camilla Boslev, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2p6pqnuq0fe472grsbssct5t7h